Families affected by SMA are pro newborn screening

An English research group investigated the general acceptance of an extended newborn screening for spinal muscular atrophy in affected families (Boardman et al). More than 70% of the investigated family members appreciated a screening program. One of the most important issues is the possibility of an optimal medical care and the participation in a clinical trial before onset.
Authors: Boardman FK, Young PJ, Griffiths FE.
Publication: Newborn screening for spinal muscular atrophy: The views of affected families and adults. Am J Med Genet A. 2017;173(6):1546-1561.